ABSTRACT
BACKGROUND Artificial intelligence has emerged as a tool to potentially increase efficiency and efficacy of cardiovascular care and improve clinical outcomes. This study aims to provide an overview of applications of artificial intelligence in cardiac surgery.
METHODS A systematic literature search on artificial intelligence applications in cardiac surgery from inception to February 2024 was conducted. Articles were then filtered based on the inclusion and exclusion criteria and risk of bias was assessed. Key findings were then summarized
RESULTS A total of 81 studies were found that reported on artificial intelligence applications in cardiac surgery. There is a rapid rise in studies since 2020. The most popular machine learning technique was Random Forest (n=48), followed by Support Vector Machine (n=33), Logistic Regression (n=32), and Extreme Gradient Boosting (n=31). Most of the studies were on adult patients, conducted in China, and involved procedures such as valvular surgery (24.7%), heart transplant (9.4%), coronary revascularization (11.8%), congenital heart disease surgery (3.5%), and aortic dissection repair (2.4%). Regarding evaluation outcomes, 35 studies examined the performance, 26 studies examined clinician outcomes, and 20 studies examined patient outcomes.
CONCLUSION Artificial intelligence was mainly used to predict complications following cardiac surgeries and improve clinicians’ decision-making by providing better preoperative risk assessment, stratification, and prognostication. While the application of artificial intelligence in cardiac surgery has greatly progressed in the last decade, further studies need to be done to verify accuracy and ensure safety before use in clinical practice.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
We had to revise the methodology of the study to include pediatric studies as well which increase the number of studies included to 80 studies. We then had to update the tables and added figures to better illustrate the studies included and the AI techniques involved. We also had to update the PRISMA figure.
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
